Summary
Dan Karlin is a physician-leader blending clinical expertise, digital medicine, and entrepreneurship to advance novel treatments for mental health and addiction. As Chief Medical Officer at Definium Therapeutics and a former founder/CEO of HealthMode, he has moved digital measurement and psychedelic-informed therapeutics from concept to regulatory milestones, including FDA clearance for a digital therapeutic at NightWare. Board-certified in Psychiatry, Addiction Medicine, and Clinical Informatics, he has led digital medicine strategy at Pfizer and holds academic appointments at Tufts, reflecting a rare mix of industry, startup, and academic impact. He advises multiple startups and boards focused on expanding access to evidence-based care, and his background in cognitive science and informatics underpins a data-driven approach to translating novel biomarkers into scalable clinical solutions. An interesting throughline: he repeatedly builds bridges between rigorous regulatory pathways and nimble product teams to turn experimental measurement tech into usable, approved clinical tools.
10 years of coding experience
9 years of employment as a software developer
MA Medical Informatics and Cognitive Science in Medicine, MA Medical Informatics and Cognitive Science in Medicine at Columbia Department of Biomedical Informatics
MD, MD at University of Colorado Anschutz
BA Neuroscience and Behavior, BA Neuroscience and Behavior at Columbia University